Practice Areas -

Corporate and M&A Law Firms and Lawyers

  • Search Result as
  • By Days
  • Between Dates

Practice Areas - Corporate and M&A Law Firms and Lawyers

Deal Date: 09-06-2020 Practice Area: Corporate and M&A
Deal Title: CSL Behring Acquisition of Vitaeris Industry: Pharmaceuticals & Biotechnology
Simpson Thacher represented CSL Behring in connection with its acquisition of Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development of clazakizumab, an anti-interleukin-6 (IL-6) monoclonal antibody (MAB), for the potential treatment of chronic active antibody-mediated rejection (AMR), the leading cause of long-term rejection in kidney transplant recipients. The companies entered into a strategic partnership in 2017 to expedite the development of clazakizumab with the option for CSL Behring to acquire Vitaeris, along with this important product candidate.
Financial Center: New York Value: 0.00-0.00
Advised Party: Acquiror Law Firm
Target Company Jurisdiction: United States Acquiror Jurisdiction: United States
Classification: Strategic Buyer Acquisitions Private Company
Lawyer Mark D Pflug